Group 1 - The company approved a guarantee for its wholly-owned subsidiary, Zhejiang Hongrun Pharmaceutical Co., Ltd., to secure a loan of up to 8 million yuan from China Merchants Bank [1][2] - The total amount of guarantees provided by the company to its subsidiaries, including this new guarantee, is 54 million yuan, which accounts for 3.04% of the company's most recent audited net assets [2] - There are no overdue guarantees or guarantees involving litigation, and all guarantees are exclusively for subsidiaries [2] Group 2 - The company signed an irrevocable maximum guarantee agreement with China Merchants Bank, which includes various fees and costs related to the guarantee [1][2] - The guarantee period extends for three years beyond the expiration of any specific credit extension [2] - The company has disclosed the relevant announcement in multiple financial publications and on its official information platform [1]
创新医疗: 关于为鸿润医药提供担保的进展公告